Template:DrugProjectForm: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 157: | Line 157: | ||
<nowiki>{{DrugReflist}}</nowiki></div> | <nowiki>{{DrugReflist}}</nowiki></div> | ||
}} | }} | ||
{{#if: {{{ | {{#if: {{{hasAdverseReactions|}}} | | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
'''Below is the code to be placed on the Adverse Reaction Microchapter:''' | '''Below is the code to be placed on the Adverse Reaction Microchapter:''' | ||
| Line 222: | Line 222: | ||
<nowiki>:'''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]'''</nowiki> | <nowiki>:'''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]'''</nowiki> | ||
{{#if: {{{ | {{#if: {{{hasUseInPregnancyAUS|}}} | | ||
{{{ | {{{useInPregnancyAUS}}} | | ||
<nowiki>There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{BASEPAGENAME}} in women who are pregnant.</nowiki> | <nowiki>There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{BASEPAGENAME}} in women who are pregnant.</nowiki> | ||
}} | }} | ||
| Line 250: | Line 250: | ||
<nowiki>===Geriatic Use===</nowiki> | <nowiki>===Geriatic Use===</nowiki> | ||
{{#if: {{{ | {{#if: {{{hasUseInGeri|}}} | | ||
{{{useInGeri}}} | | {{{useInGeri}}} | | ||
<nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} in geriatric settings.</nowiki> | <nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} in geriatric settings.</nowiki> | ||
| Line 264: | Line 264: | ||
<nowiki>===Race===</nowiki> | <nowiki>===Race===</nowiki> | ||
{#if: {{{hasUseInRace|}}} | | {{#if: {{{hasUseInRace|}}} | | ||
{{{useInRace}}} | | {{{useInRace}}} | | ||
<nowiki>There is no FDA guidance on the use of {BASEPAGENAME}} with respect to specific racial populations.</nowiki> | <nowiki>There is no FDA guidance on the use of {BASEPAGENAME}} with respect to specific racial populations.</nowiki> | ||
| Line 278: | Line 278: | ||
<nowiki>===Hepatic Impairment===</nowiki> | <nowiki>===Hepatic Impairment===</nowiki> | ||
{{#if: {{{ | {{#if: {{{hasUseInHepaticImpair|}}} | | ||
{{{useInHepaticImpair}}} | | {{{useInHepaticImpair}}} | | ||
<nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} in patients with hepatic impairment.</nowiki> | <nowiki>There is no FDA guidance on the use of {{BASEPAGENAME}} in patients with hepatic impairment.</nowiki> | ||
| Line 292: | Line 292: | ||
<nowiki>===Immunocompromised Patients===</nowiki> | <nowiki>===Immunocompromised Patients===</nowiki> | ||
{{#if: {{{ | {{#if: {{{hasUseInImmunocomp|}}} | | ||
{{{useInImmunocomp}}} | | {{{useInImmunocomp}}} | | ||
<nowiki>There is no FDA guidance one the use of {{BASEPAGENAME}} in patients who are immunocompromised.</nowiki> | <nowiki>There is no FDA guidance one the use of {{BASEPAGENAME}} in patients who are immunocompromised.</nowiki> | ||
Latest revision as of 20:17, 20 March 2014
This is the "Drug Project Form" template. It should be called in the following format:
{{DrugProjectForm
|hasBlackBoxWarning=
|blackBoxWarningTitle=
|blackBoxWarningBody=
|fdaLIADAdult=
|offLabelAdult=
|fdaLIADPed=
|offLabelPed=
|contraindications=
|warnings=
|adverseReactions=
|clinicalTrials=
|postmarketing=
|drugInteractions=
|hasUsageInfo=
|hasUseInPregnancyFDA=
|useInPregnancyFDA=
|hasUseInPregnancyAUS=
|useInPregnancyAUS=
|hasUseInLaborDelivery=
|useInLaborDelivery=
|hasUseInNurshing=
|useInNursing=
|hasUseInPed
|useInPed=
|hasUseInGeri=
|useInGeri=
|hasUseInGender
|useInGender=
|hasUseInRace
|useInRace=
|hasUseInRenalImpair=
|useInRenalImpair=
|hasUseInHepaticImpair=
|useInHepaticImpair=
|hasUseInReproPotential=
|useInReproPotential=
|hasUseInImmunocomp=
|useInImmunocomp=
|routes=
|preparations=
|IVCompat=
|overdose=
|mechAction=
|structure=
|PD=
|PK=
|nonClinToxic=
|clinicalStudies=
|howSupplied=
|drugImages=
|packLabel=
|fdaPatientInfo=
|nlmPatientInfo=
|price=
|drugShortage=
}}
Edit the page to see the template text.